Amblyopia Treatment for Children Aged 8 to 12 Years
Recruiting now · Not applicable
Conditions studied: Amblyopia
In brief
This study is being done to assess the effect of at-home amblyopia treatment with Curesight™ for children aged 8 to 12 years. Curesight™ allows you to stream any videos on a computer screen at home but the amblyopic eye will see the entire screen clearly while part of the image will be blurred for the other eye. There is already a pivotal clinical trial showing that this treatment is effective for young children and Curesight™ has been cleared for use as an amblyopia treatment by the FDA for children as young as 4 years.
Key facts
- Study ID
- NCT07281742
- Run by
- Retina Foundation of the Southwest
- People needed
- 30
- Starts
- 2025-01-07
- Expected to finish
- 2028-06-30
- Last updated by the study team
- 2025-12-15
Who can join
Age: 8 and older, up to 12. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Female and male children with amblyopia age 8-12 years inclusive
- Amblyopic eye visual acuity ≤ 1.0 logMar (20/32-20/200)
- Interocular difference in visual acuity of 0.3 logMAR or more
- Anisometropia or strabismus corrected to <5 pd
- Wearing glasses (if needed) ≥8 weeks
- No longer using standard-of-care treatments for amblyopia
- Informed consent
You may not qualify if…
- Prematurity >8 weeks
- Coexisting ocular or systemic disease
- Developmental delay
- History of light-induced epilepsy
- Eye conditions that interfere with eye tracking (nystagmus, wearing RGP contact lenses, paralysis of the extra ocular muscles or any neurological condition that restricts eye movements, ptosis that covers the pupil)
Where it is running
- Retina Foundation of the Southwest — Dallas, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.